Patients (n=65) (n, %) | Average time to start per therapy (median, IQR) | |
---|---|---|
Methotrexate | 41 (82) | 13 (7–57) |
Hydroxychloroquine | 6 (12) | 19 (12–606) |
Sulfasalazine | 1 (2) | 10 |
Leflunomide | 2 (4) | 16 resp 189 weeks |
Other drug | 5 (23) | 82 (25–336) |
No therapy started | 10 (15) | – |
All therapies | 55 (85) | 15 (5–81) |